Streptococcus pneumoniae is an infrequent cause of infectious endocarditis in adults. In the past 2 years, however, we have encountered several cases at our institution, and additional cases have been reported in the literature. This infection typically follows pneumonia in the setting of chronic alcoholism and may additionally be complicated by meningitis. Less commonly, pneumococcal endocarditis occurs in other hosts or follows primary infection at other extrapulmonary sites. In such cases, the diagnosis may be initially missed, with a resultant delay in institution of appropriate therapy. Moreover, there are controversies regarding the optimal therapy for infections of this nature in the era of penicillin resistance. Since a comprehensive review of this topic has not been published since 1990, we reviewed cases of pneumococcal endocarditis in the penicillin era, with particular attention to disease recognition, the role of echocardiography, and the dilemmas surrounding medical and surgical therapeutic interventions.
Streptococcus pneumoniae is an infrequent cause of bacterial language literature, we identified a total of 197 adult cases of pneumococcal endocarditis in the penicillin era. For each endocarditis in adults, accounting for õ3% of cases since the advent of penicillin in the early 1940s [1 -6] . The classic pre-reported case, the following data were extracted when available: patient demographics; preexisting medical conditions, in-sentation is acute Osler's triad of pneumonia, meningitis, and endocarditis in an alcoholic. The usual portal of entry for infec-cluding alcoholism and valvular heart disease; length of illness before presentation; likely portal of entry and concurrent sites tion in this setting is the lung. Less commonly, pneumococcal endocarditis occurs in other hosts or follows primary infection of pneumococcal infection (pneumonia and meningitis); valve(s) involved; local and systemic complications (i.e., the at other extrapulmonary sites. In such cases, the diagnosis may be delayed because of a lower index of suspicion. Despite the presence and degree of valvular insufficiency, congestive heart failure, shock, or embolic events); echocardiographic findings; availability of penicillin, the mortality rate associated with this disease remains high, with case-fatality rates ranging from 28% pneumococcal capsular serotype; antibiotic regimen; clinical outcome; surgery and/or autopsy findings; and likely cause of to 60% [4, 7, 8] .
The occurrence of several recent cases of pneumococcal death. endocarditis at our hospital (authors' unpublished data) and in the literature [9 -11] prompted us to conduct an in-depth review Results of the English-language literature on this subject. A review of this kind has not been done since 1990 [1] . We were able to One hundred ninety-seven adult cases of pneumococcal enidentify 197 adult cases of pneumococcal endocarditis ocdocarditis were identified from the penicillin era [1 -4, 6 -9, curring in the penicillin era. Given it is likely that additional 12 -50]. As shown in table 1, the male-to-female ratio was cases of pneumococcal endocarditis go unreported, we believe 2.5:1, and the mean age of the patients was 52 years. The that the prevalence of this disease is high enough to warrant a most common associated medical problem was alcoholism, review of the relevant clinical issues, with particular attention identified in 28.1% of cases. Thirteen percent of patients had to predisposing risk factors, clinical presentation, diagnosis, underlying valvular heart disease. However, for 47.4% of pamanagement, and anticipated outcome. tients, no comorbidity was identified. Patients typically presented without peripheral stigmata of infective endocarditis.
Methods
The median duration of illness before presentation was 7 Using MEDLINE from 1966 to the present and reference days. The lung was the usual portal of entry (82.2% of cases), lists from reviewed articles and textbooks in the Englishalthough an ear, nose, sinus, and/or throat source was identified in 13.7% of cases. Meningitis was a common complication (59.5% of cases). Of the cases complicated by meningitis, 29 [57] in 1862 and subsequently by Osler [58] in 1881 (the year that pneumococcus was discovered). Since that time, a Among the 37 patients whose cases were managed with a combined medical-surgical approach [1 -4, 7, 8, 13, 14, 17, number of investigators have linked pneumococcal endocarditis with alcoholism [7, 13 -16, 59] , transforming Osler's 23 -26, 41, 42], the mortality rate was 32%, as compared with 62% among the 91 patients treated with antibiotics alone.
original triad into a tetrad [16] . Precisely why alcoholism predisposes individuals to serious invasive pneumococcal disease, including endocarditis, re-Discussion mains unclear. An array of immunologic defects have been described in alcoholics, any of which might contribute to sus-Pneumococcal endocarditis is considered a rare entity. However, the true prevalence and incidence of this disease are tained bacteremia and risk of endocardial infection; these defects include leukocyte defects such as impaired chemotaxis, unknown since the literature primarily consists of case reports and small case series. In the preantibiotic era, S. pneumoniae a dysfunctional reticuloendothelial system due to impaired expression of Fc receptors, and impaired delayed-type hypersen-was responsible for Ç15% of all cases of infective endocarditis [51] . From review of the available data since the advent of sitivity [16, 60 -62] . However, it remains unclear which, if any, of these abnormalities can be directly attributed to alcohol. penicillin, the prevalence appears to have significantly declined and is now estimated to range from 1% to 3% [1 -6]. This Most researchers believe that the effect of alcohol and alcoholism on host immunity is multifactorial, stemming not only decline is presumably due to early administration of appropriate antimicrobial therapy, resulting in either prevention or rapid from various immunologic defects as described but also from malnutrition and the propensity to aspiration. control of bacteremia and thus a decreased incidence of endocardial seeding. Despite this overall decline in prevalence, how-Failure to receive the pneumococcal vaccine has also been proposed as a risk factor for invasive pneumococcal disease, ever, we identified 197 adult cases of pneumococcal endocarditis occurring in the penicillin era.
when controlling for vaccinated host populations [63, 64] . The aim of pneumococcal vaccination is to prevent the development The risk factors that predispose individuals to pneumococcal endocarditis remain incompletely defined, but likely these fac-of systemic disease due to any of the vaccine's 23 pneumococcal serotypes. However, it is unknown whether vaccination tors parallel those that predispose individuals to invasive pneumococcal disease in general. In the immunocompetent host, affords protection against pneumococcal endocarditis. Previous reports of pneumococcal endocarditis often failed to provide following establishment of localized S. pneumoniae infection, an array of host immune responses are normally elicited that adequate data on either the infecting pneumococcal serotype [1, 2, 4, 7 -9, 12, 13, 16 -37] or patients' vaccination histories act to contain infection and rapidly clear bacteremia when it does occur. These responses are both humoral and cellular [1, 7 -9, 12, 15, 16, 18 -50] . Although a number of series described pneumococcal endocarditis in patients who did not in nature and local and systemic in distribution; they include induction of IgG and IgA antibodies that are directed primarily receive the pneumococcal vaccine [2, 4, 13, 17] , there are little data regarding infection occurring in the setting of prior at the pneumococcal capsule, activation of the complement pathways, and mobilization and activation of various phago-vaccination.
In one series of nine Alaskan natives with pneumococcal endo-cytic effectors [52] . A variety of conditions that impact on host immunity may thus predispose individuals to sustained carditis [14] , two patients had received the 14-valent pneumococcal vaccine 4 to 5 years previously. One patient had no known bacteremia and/or serious invasive pneumococcal disease, including those associated with impaired antibody generation, medical problems and developed endocarditis due to serotype 23 that was represented in the vaccine, while the other patient was quantitative or qualitative neutrophil defects, and/or defective function of the reticuloendothelial system. an alcoholic with chronic pulmonary disease who developed infection due to a strain that was not serotyped. The investigators Identified risk factors for invasive pneumococcal disease include conditions that affect local clearance mechanisms (such noted the apparent inability of previous vaccination to prevent infection in their patients and suggested that certain serotypes as chronic tobacco use, recent respiratory infection, and chronic pulmonary disease) and conditions characterized by impaired may be poorly immunogenic. They did not comment on the fact that most people who receive the vaccine have an antibody systemic host immune responses (such as extremes of age, malnutrition, chronic glucocorticoid therapy, various chronic response to only 75% of the antigens included. Furthermore, elderly patients and those with alcoholism and/or chronic pulmo-disorders [cirrhosis, renal insufficiency, and diabetes mellitus], HIV infection, other congenital or acquired immunodeficien-nary disease are likely to respond suboptimally to vaccination and have a more rapid decline in antibody titer to nonprotective cies, and alcoholism) [12, 53 -56] .
Of the aforementioned factors, alcoholism is one of the levels over time [63] [64] [65] [66] [67] .
In terms of clinical presentation, patients typically develop strongest risk factors for pneumococcal endocarditis. The triad of pneumonia, meningitis, and endocarditis following pneumococcal endocarditis following pneumococcal infection elsewhere, at a site usually within the upper or lower respiratory infection with pneumococcus was first described by Heschl / 9c43$$ja75 11-26-97 09:50:23 cidas UC: CID tract [3, 4]. Early reviews of pneumococcal endocarditis de-The diagnosis of infective endocarditis is in large part clinical. Echocardiography, however, plays an important role in scribed older patients who had the typical Osler's triad. These patients presented with pneumococcal pneumonia following confirming the diagnosis, particularly in cases where either the infecting pathogen and/or the host involved makes the diagno-which, after a brief apparent recovery, they developed fever, sepsis, and cardiac failure due to acute valve infection and sis challenging. In addition, echocardiography provides critical noninvasive information regarding function and status of valves destruction. Most of these patients died of purulent pneumococcal meningitis within 30 days of the onset of pneumonia. Our and paravalvular structures and, as a result, helps determine the need for as well as timing of surgical intervention. Recent review confirms that the lung continues to be the most common portal of entry for pneumococcal endocarditis.
studies have demonstrated that the sensitivity and specificity of transesophageal echocardiography (TEE) for detecting valvular Much less commonly, adult cases of pneumococcal endocarditis have followed sinusitis, mastoiditis, otitis media, vegetations and associated complications are superior to those of TTE [70] . Our review confirms the limited diagnostic sensi-tooth extraction, and septic abortion [3, 7, 9, 20] . Although some of these patients were presumably receiving oral antibi-tivity of TTE for pneumococcal endocarditis in that potentially life-threatening complications such as valvular perforation and otic therapy prior to developing endocarditis, most investigators failed to provide the details of therapy; thus, the explana-paravalvular abscess went undetected in 42% and 100% of cases, respectively. tion for the occurrence of endocarditis remains unclear, with possible contributors being predisposing host risk factors, By comparison, there are only limited data on the diagnostic utility of TEE for this particular infection. From our review, we antibiotic resistance, and/or suboptimal serum drug concentration. Three prior reports described pneumococcal endocar-identified only two cases in which patients with pneumococcal endocarditis underwent TEE [9, 25] . In one case, TEE disclosed ditis developing in patients being treated empirically for a preexisting condition (i.e., urinary tract infection, recurrent a mobile mass on the insertion ring of a prosthetic valve, which was associated with paravalvular reflux; this patient survived fever and chills, and pneumonia) with an antibiotic to which S. pneumoniae either was [38] or should have been [1, 4] without surgical intervention. In a second case, TEE was employed to evaluate the possibility of a ring abscess in a woman susceptible. Further details are needed, however, to better understand why oral antibiotic therapy failed to prevent bac-with a TTE-confirmed aortic valve vegetation and prolongation of the PR interval on electrocardiogram. No abscess was de-teremia in these particular cases.
Once endocardial infection is established, the course of tected, and the patient did well with medical therapy alone. These cases illustrate the major role TEE can play in guiding pneumococcal endocarditis is typically aggressive and is associated with high morbidity and mortality rates. This poor the need for surgical vs. medical therapy in known cases of pneumococcal endocarditis. Given the superior sensitivity of outcome stems from a variety of factors. First, the presentation is generally acute. Patients typically lack peripheral stig-TEE over TTE, its use in such cases will likely translate into improved outcome due to earlier detection of potentially fatal mata of endocarditis that may contribute to a delay in diagnosis and initiation of appropriate antibiotic therapy. Second, complications.
Patients with pneumococcal endocarditis may be treated for reasons that remain incompletely defined but likely pertain to the host as well as the organism itself, rapid destruc-either medically or via a combined medical-surgical approach. With regard to antimicrobial therapy, the optimal tion of endothelial tissue generally occurs followed by acute valvular insufficiency, congestive heart failure, and, in a regimen remains unclear in the era of penicillin-resistant S. pneumoniae. Parenterally administered penicillin has tradi-smaller percentage of cases, early death [3, 4, 13] . A subset of patients have been described, however, who manifest a tionally been the antibiotic of choice for treatment of serious pneumococcal infections; however, worldwide rates of multi-more subacute presentation [4, 19] .
Third, cardiac and extracardiac sequelae are common, in drug-resistant S. pneumoniae are increasing, and in the United States, the rate of multidrug resistance ranges from particular hemodynamic instability secondary to valve perforation, abscess formation, and systemic embolization. This occur-0 to 28% depending on the area and age group [71] . Although there are data [72] related to the use of high doses of penicillin rence is in part due to the fact that, although S. pneumoniae may infect either native or prosthetic valves, it appears to for the treatment of pneumonia due to either intermediateor high-level penicillin-resistant strains of pneumococcus, have a predilection for the aortic valve [2 -4, 6, 8, 14, 16, 20, 39, 59] (which, as compared with other infected heart valves, data are currently lacking for similar cases of either endocarditis or meningitis. In such cases, there is an increased inocu-is associated with the highest rate of local complications). In addition, the vegetations that form tend to be large, predispos-lum of organisms, and successful outcome mandates achievement of bactericidal concentrations of drug. In the setting of ing individuals to systemic embolization [68, 69] . Our review confirms that for pneumococcal endocarditis in general, as well penicillin resistance, even intermediate-level resistance, high doses of intravenous penicillin may not achieve an adequate as for those cases associated with the highest rate of complications, the aortic valve is most commonly affected. tissue concentration of antibiotic. Accordingly, recommenda-/ 9c43$$ja75 11-26-97 09:50:23 cidas UC: CID tions regarding empirical therapy for pneumococcal endocar-does, however, mandate the need for highly sensitive diagnostic modalities, such as TEE, to guide the timing of surgi-ditis should likely parallel those recently adopted for pneumococcal meningitis [73] . cal intervention. In conclusion, although the incidence of pneumococcal There are only two case reports [9, 10] that detail the outcome of pneumococcal endocarditis caused by penicillin-endocarditis has decreased since the advent of penicillin, cases of pneumococcal endocarditis still occur and are asso-resistant S. pneumoniae isolates. The first case [10] was a 2-year-old boy who received cefteram and cefpodoxime for ciated with a poor outcome. The poor prognosis of this disease has been attributed to both host and microbial factors, treatment of a febrile illness 2 weeks before being hospitalized because of pneumococcal endocarditis involving the mitral including older age, alcoholism, diabetes, and other concomitant diseases as well as the organism's propensity to infect valve. His blood isolate was highly resistant to penicillin (MIC, 6.25 mg/mL) and ceftriaxone (MIC, 6.25 mg/mL) but was sus-and rapidly destroy left-sided heart valves. Although the disease occurs most commonly in alcoholics, other host pop-ceptible to imipenem (MIC, 0.2 mg/mL) and cefuzonam (MIC, 0.39 mg/mL). The child responded successfully to medical ulations may be affected, and their presentation may be somewhat unusual. The aggressive nature of this infection treatment alone following an 11-week course of sequential parenteral therapy with imipenem, cefuzonam, and ampicillin. The makes early diagnosis and treatment crucial. TEE serves as a rapid means of assessing valve status (including compe-second case [9] was a 63-year-old woman who received 2 days of an unspecified oral antibiotic for treatment of otitis media tency, level of destruction, and presence or absence of paravalvular abscesses) and thus determines the need for as well 2 weeks before being hospitalized because of pneumococcal endocarditis involving the aortic valve. Her blood isolate was as timing of surgical intervention. Given the widespread and variable prevalence of b-lactam-agent-resistant S. pneumo-highly resistant to penicillin (MIC, 6 mg/mL) and ceftriaxone (MIC, 6 mg/mL) but was susceptible to rifampin (MIC, niae, empirical therapy should likely consist of one of the more reliable higher-generation cephalosporins (i.e., ceftri-1 mg/mL) and vancomycin (MIC, 0.75 mg/mL). The patient was treated successfully with a 6-week course of vancomycin axone, cefotaxime, or cefepime) with or without vancomycin, depending on the prevalence of cephalosporin-resistant and rifampin.
Although no formal recommendations can be made at this S. pneumoniae in one's geographic area. A combined medical-surgical approach, employing a prolonged course of par-time regarding the optimal empirical therapy for patients with suspected or documented pneumococcal endocarditis, on the enteral antibiotics (4 -6 weeks) plus early valve replacement, appears to result in a lower rate of attributable mortality and basis of the aggressive nature of this disease as well as the risk of associated meningitis (pending formal susceptibility patterns should therefore be strongly considered. for the isolate), it seems reasonable to provide treatment for such patients similar to the current recommendation for those lin-resistant pneumococci. The improved outcome for pa- 
